Acquired myasthenia gravis (MG) is an autoimmune disorder of the neuromuscular junction
in which patients experience fluctuating skeletal muscle weakness that often affects selected …

The thymus plays distinct roles in the pathogenesis of the different Myasthenia gravis (MG)
subtypes. Inflammatory, neoplastic and age-related alterations of the thymus are of pivotal …

Myasthenia gravis (MG) is characterized by muscle weakness and fatigue caused by the
presence of autoantibodies against the acetylcholine receptor (AChR) or the muscle-specific …

Myasthenia gravis is an autoimmune disorder of the neuromuscular junction. A number of
molecules, including ion channels and other proteins at the neuromuscular junction, may be …

Purpose A key challenge in the treatment of thymoma and thymic carcinoma (TC) is in
improving our understanding of the molecular biology of these relatively rare tumors. In …

Patients with thymic malignancy have high rates of autoimmunity leading to a variety of
autoimmune diseases, most commonly myasthenia gravis caused by anti-acetylcholine …

Anticytokine autoantibodies are an emerging mechanism of disease in previously healthy
adults. Patients with these syndromes demonstrate a unique infectious phenotype …

Background. Good syndrome (GS) is a rare condition in which thymoma is associated with
hypogammaglobulinemia. It is characterized by increased susceptibility to bacterial, viral …

Thymoma-associated Myasthenia gravis (TAMG) is one of the anti-acetylcholine receptor
MG (AChR-MG) subtypes. The clinico-pathological features of TAMG and its pathogenesis …

Myasthenia gravis (MG) is an autoimmune disease affecting the neuromuscular junction
(NMJ), whose clinical hallmark is muscle weakness and early fatigability. The main target of …